Hypercholesterolemia Treatment Patterns and Low-Density Lipoprotein Cholesterol Monitoring in Patients with a Diagnosis of Atherosclerosis in Clinical Practice

American Journal of Medicine

Volumn 122, Issue 1 SUPPL., 2009, Pages

  Davidson, Michael H ^a   Gandhi, Sanjay K ^b   Ohsfeldt, Robert L ^c   Fox, Kathleen M ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b ASTRAZENECA   (United Kingdom)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Hypercholesterolemia; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DIAGNOSTIC VALUE; DYSLIPIDEMIA; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; REFERENCE DATABASE; RETROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT RESPONSE;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 57749086141     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.10.017     Document Type: Article

References (19)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 (1997) 1498-1504
2. Robinson J.G., and Leon A.S. The prevention of cardiovascular disease: emphasis on secondary prevention. Med Clin North Am 78 (1994) 69-98
3. Patrick D.L., and Erickson P. Health Status and Health Policy: Allocating Resources to Health Care (1993), Oxford University Press, New York 1-478
4. Khoury Z., Schwartz R., Gottlieb S., Chenzbraun A., Stern S., and Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 80 (1997) 1429-1433
5. Hankey G.J., Jamrozik K., Broadhurst R.J., Forbes S., Burvill P.W., Anderson C.S., and Stewart-Wynne E.G. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 31 (2000) 2080-2086
6. Kannel W.B., and Wolf P.A. Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham study. Curr Atheroscler Rep 8 (2006) 317-323
7. Castelli W. Lipoproteins and cardiovascular disease: biological basis and epidemiological studies. Value Health 1 (1998) 105-109
8. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
9. Pyorala K., and Wood D. Prevention of coronary heart disease in clinical practice: European recommendations revised and reinforced. Eur Heart J 19 (1998) 1413-1415
10. DeBacker G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24 (2003) 1601-1610
11. Nissen S.E., Nicholls S.J., Sipahi I., et al., ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
12. Crouse III J.R., Raichlen J.S., Riley W.A., et al., METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial. JAMA 297 (2007) 1344-1353
13. Nissen S.E., Tuzcu E.M., Brown B.G., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
14. Pearson T.A., Laurora I., Chu H., and Kafonek S. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
15. Davidson M.H., Maki K.C., Pearson T.A., et al. Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP writing group recommendations. Am J Cardiol 96 (2005) 556-563
16. Grundy S.M., Cleeman J.I., Merz C.N., et al., Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 44 (2004) 720-732
17. Jensen L.O., Thayssen P., Pedersen K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 110 (2004) 265-270
18. Okazaki S., Yokoyama T., Miyauchi K., Shimada K., Kurata T., Sato H., and Daida H. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 110 (2004) 1061-1068
19. Kiechl S., Willeit J., and Bruneck Study Group. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol 19 (1999) 1484-1490